Michael Birrer
Michael Birrer
Professor Medicine HMS
Verified email at partners.org
Title
Cited by
Cited by
Year
Integrated genomic analyses of ovarian carcinoma
Cancer Genome Atlas Research Network
Nature 474 (7353), 609, 2011
38452011
Integrated genomic characterization of endometrial carcinoma
DA Levine
Nature 497 (7447), 67-73, 2013
28222013
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
M Verheij, R Bose, XH Lin, B Yao, WD Jarvis, S Grant, MJ Birrer, E Szabo, ...
Nature 380 (6569), 75-79, 1996
21391996
Making technology our own?: domesticating technology into everyday life
M Lie, KH Sørensen
Scandinavian University Press, 1996
2098*1996
Incorporation of bevacizumab in the primary treatment of ovarian cancer
RA Burger, MF Brady, MA Bookman, GF Fleming, BJ Monk, H Huang, ...
New England Journal of Medicine 365 (26), 2473-2483, 2011
19942011
p53: a frequent target for genetic abnormalities in lung cancer
T Takahashi, MM Nau, I Chiba, MJ Birrer, RK Rosenberg, M Vinocour, ...
Science 246 (4929), 491-494, 1989
14911989
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
13092018
Integrated genomic analyses of ovarian carcinoma
D Bell, A Berchuck, M Birrer, J Chien, DW Cramer, F Dao, R Dhir, ...
Nature Publishing Group, 2011
12122011
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
10102018
BRCA mutation frequency and patterns of treatment response in BRCA mutation–positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group
K Alsop, S Fereday, C Meldrum, A DeFazio, C Emmanuel, J George, ...
Journal of Clinical Oncology 30 (21), 2654, 2012
9652012
Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73
T Smeal, B Binetruy, DA Mercola, M Birrer, M Karin
Nature 354 (6353), 494-496, 1991
9251991
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
8982018
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
8022018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
8012018
Dicer, Drosha, and outcomes in patients with ovarian cancer
WM Merritt, YG Lin, LY Han, AA Kamat, WA Spannuth, R Schmandt, ...
New England Journal of Medicine 359 (25), 2641-2650, 2008
7852008
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
RL Coleman, AM Oza, D Lorusso, C Aghajanian, A Oaknin, A Dean, ...
The Lancet 390 (10106), 1949-1961, 2017
7322017
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast, V Beral, JS Berek, ...
Nature reviews Cancer 15 (11), 668-679, 2015
6712015
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
L Zhang, S Volinia, T Bonome, GA Calin, J Greshock, N Yang, CG Liu, ...
Proceedings of the National Academy of Sciences 105 (19), 7004-7009, 2008
6452008
Finite-state language processing
E Roche, Y Schabes
MIT press, 1997
518*1997
Early events in the pathogenesis of epithelial ovarian cancer
CN Landen Jr, MJ Birrer, AK Sood
Journal of Clinical Oncology 26 (6), 995-1005, 2008
5152008
The system can't perform the operation now. Try again later.
Articles 1–20